Sort
21,281 grants matching “influenza”
Toll-like receptor control of endocytic antigen cross-presentation
$675,627Julie Magarian Blander · Weill Medical Coll Of Cornell Univ · R01 · FY2025 · AI
Hospital and Household Studies of Respiratory Cryptosporidiosis and Transmission
$675,368Jeffrey K Griffiths · Tufts University Boston · R01 · FY2016 · AI
Dynamics of Influenza Transmission in Nicaraguan Households
$675,264Aubree L Gordon · University Of Michigan At Ann Arbor · R01 · FY2021 · AI
Pre-clinical Vaccine and Antibody Development for Coronavirus Disease
$675,181Wing Pui Kong · National Institute Of Allergy And Infectious Diseases · ZIC · FY2025 · AI
Genetic regulation and immunological function of ERAP2 haplotypes
$675,118Chun Jimmie Ye · University Of California, San Francisco · R01 · FY2021 · AI
Biophysical studies of macromolecules and molecular assemblies
$675,045Steven G. Boxer · Stanford University · R35 · FY2025 · GM
Biophysical studies of macromolecules and molecular assemblies
$675,045Steven G. Boxer · Stanford University · R35 · FY2024 · GM
Skin Vaccination Against Influenza in the Young And Aged
$674,916Richard W Compans · Emory University · R01 · FY2016 · AI
Skin Vaccination Against Influenza in the Young And Aged
$674,916Richard W Compans · Emory University · R01 · FY2017 · AI
Regulation of viral-bacterial co-infections by immunometabolism
$674,449Jennifer Melinda Bomberger · Dartmouth College · R01 · FY2024 · HL
Biophysical studies of macromolecules and molecular assemblies
$674,362Steven G. Boxer · Stanford University · R35 · FY2022 · GM
Cincinnati Children's Hospital Medical Center Vaccine and Treatment Evaluation Units (UM1 Clinical Trial Required)
$674,143Robert Wilson Frenck · Cincinnati Childrens Hosp Med Ctr · UM1 · FY2022 · AI
Vaccine Development Of Nontypeable Haemophilus influenzae/Moraxella catarrhalis
$673,976Xin-Xing Xing Gu · Deafness & Other Communication Disorders · Z01 · FY2007 · DC
Genetic Epidemiology of Life-Threatening Influenza in Children
$673,800Adrienne G Randolph · Boston Children'S Hospital · R01 · FY2010 · AI
Cellular and molecular mechanisms of alveolar repair
$673,790Tushar Jasubhai Desai · Stanford University · R01 · FY2023 · HL
Topical adjuvants to enhance the efficacy of influenza vaccines
$673,631Carol O Cowing · Lancell, Llc · R44 · FY2010 · AI
Deep sequencing of pathogens to precisely define transmission networks using rare variants
$673,574William Hanage · Harvard School Of Public Health · R01 · FY2017 · AI
Aging Intervention Studies
$673,491Julie Mattison · National Institute On Aging · ZIA · FY2015 · AG
Cellular and molecular mechanisms of alveolar repair
$673,485Tushar Jasubhai Desai · Stanford University · R01 · FY2025 · HL
RI DEPT OFHLTH PANDEMIC INFLUENZA PROPOSAL TO ADDRESS VULNERABILITIES
$673,415Katherine McCarthy-Barnett · Rhode Island State Dept Of Health · U90 · FY2008 · TP
Inhalation Therapy Platform for Coronavirus Infection Treatment
$673,364Patrick S. Stayton · University Of Washington · R01 · FY2025 · AI
Task A44: Mouse Models for the Evaluation of Influeza Therapeutics
$673,000Utah State University · N01 · FY2012 · AI
Replication of influenza virus
$672,998Robert M Krug · University Of Texas At Austin · R01 · FY2010 · AI
Evolution and Transmission of Influenza Virus in Natural Human Infection
$672,995Adam Lauring · University Of Michigan At Ann Arbor · R01 · FY2024 · AI
SCH: EXP: Smart integration of community crowdsourced data for real-time individualized disease risk assessment
$672,956Rumi Chunara · Children'S Hospital Corporation · · FY2013 · CSE